Roy Y Calne1. Show Affiliations » 1. Department of Surgery University of Cambridge, United Kingdom.
Abstract
Entities: Chemical
Mesh： See more » AlemtuzumabAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntibodies, Neoplasm/therapeutic useFollow-Up StudiesGraft Rejection/epidemiologyGraft Rejection/prevention & controlHumansImmunosuppressive Agents/therapeutic useLiver Transplantation/immunologyPostoperative Complications/epidemiologyTime Factors
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, NeoplasmImmunosuppressive AgentsAlemtuzumab
Year: 2005 PMID： 15719401 DOI： 10.1002/lt.20366
Source DB: PubMed Journal: Liver Transpl ISSN： 1527-6465 Impact factor: 5.799